Biofilm growth on implants: Bacteria prefer plasma coats

International Journal of Artificial Organs

Volumn 34, Issue 9, 2011, Pages 811-817

  Wagner, Christof ^a   Aytac, Sara ^a,b   Maria Hansch G ^b  

^a BG Trauma Center Ludwigshafen   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adherence; Bacterial biofilm; Implants; Osteitis; Plasma; Titanium

Indexed keywords

ADHESION; BACTERIA; BIOFILMS; BODY FLUIDS; CELL CULTURE; COATINGS; PROTEINS;

ADHERENCE; BACTERIAL BIOFILM; BIOFILM FORMATION; BIOLOGICAL SURFACES; IMPLANT; MICROENVIRONMENTS; OSTEITI; PLASMA PROTEIN; S. AUREUS; TITANIA;

TITANIUM;

PLASMA PROTEIN; TITANIUM;

ARTICLE; BACTERIUM ADHERENCE; BIOFILM; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MATERIAL COATING; MONOLAYER CULTURE; NONHUMAN; OPSONIZATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY;

EID: 81355136178     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000061     Document Type: Article

References (54)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial Biofilms: a common cause of persistent infections. Science. 1999;284:1318-1322. Medline. doi:10.1126/science. 284.5418.1318
2. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677-701. Medline. doi:10.1146/annurev.micro.57.030502.090720
3. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial Biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95-108. Medline. doi:10.1038/nrmicro821
4. Lynch SA, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008;59:415-428. Medline. doi:10.1146/ annurev.med.59.110106.1320005.
5. Agarwal A, Singh KP, Jain A. Medical significance and management of staphylococcal biofilm. FEMS Immunol Med Microbiol. 2010;58:147-160. Medline. doi:10.1111/j.1574- 695X.2009.00601.x
6. Harro JM, Peters BM, O'May GA, et al. Vaccine development in Staphylococcus azreus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol. 2010;59:306-323.
7. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37-44. Medline. doi:10.1111/j.1524-475X.2007.00321.x
8. Wolcott RD, Rhoads DD, Bennett ME, et al. Chronic wounds and the medical biofilm paradigm. J Wound Care. 2010;19(2):45-52.
9. Donlan RM. Biofilms and device associated infections. Emerg Infect Dis. 2001;7(2):277-281. Medline. doi:10.3201/ eid0702.010226
10. Gottenbos B, Busscher HJ, Van Der Mei HC, Nieuwenhuis P. Pathogenesis and prevention of biomaterial centered infec tions. J Mater Sci Mater Med. 2002;13(8):717-722. Medline. doi:10.1023/A:1016175502756
11. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645-1654. Medline. doi:10.1056/NEJMra040181
12. Arciola CR, Alvi FI, An YH, Campoccia D, Montanaro L. Implant infection and infection resistant materials: a mini review. Int J Artif Organs. 2005;28(11):1119-1125.
13. Poultsides LA, Liaropoudis LL, Malizos KN. The socioeconomic impact of musculoskeletal infections. J Bone Joint Surg Am. 2010;92(11):e13. Medline. doi:10.2106/JBJS.I.01131
14. Arciola CR, An YH, Campoccia ME, Donati ME, Montanaro L. Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs. 2005;28(11):1091-1100.
15. PJ. Infection in orthopaedic implants. J Hosp Infect. 1991;18 Suppl A:367-375.
16. Geipel U, Herrmann M. The infected implant: bacteriology. Unfallchirurg. 2005;108:961-975.
17. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34-39. Medline. doi:10.1016/S0966-842X(00)01913-2
18. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002;292(2):107-113. Medline. doi:10.1078/1438-4221-00196
19. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2(2):114-122. Medline. doi:10.1038/nrd1008
20. Aslam S. Effect of antibacterials on biofilms. Am J Infect Control. 2008;36(10):S175.e9-e11. Medline. doi:10.1016/j. ajic.2008.10.002
21. K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol. 2008;322:107-131. doi:10.1007/978-3-540-75418-3_6
22. Leid JG, Shirtliff HC, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun. 2002;70(11):6339-6345. Medline. doi:10.1128/IAI.70.11.6339-6345.2002
23. Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 2003;171(8):4329-4339.
24. Jensen PO, Bjarnsholt T, Phipps R, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing- controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology. 2007;153(Pt 5):1329-1338. Medline. doi:10.1099/mic.0.2006/003863-0
25. Alhede M, Bjarnsholt T, Jensen PO, et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology. 2009;155(Pt 11):3500-3508. Medline. doi:10.1099/mic.0.031443-0
26. Wagner C, Kondella K, Bernschneider T, Heppert V, Wentzensen A, Hänsch GM. Post-traumatic osteitis: analysis of inflammatory cells recruited into the site of infection. Shock. 2003;20:503-510. Medline. doi:10.1097/01. shk.0000093542.78705.e3
27. Wagner C, Kaksa A, Müller W, et al. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity, but generate superoxides. Shock. 2004;22:108-115. Medline. doi:10.1097/01. shk.0000132488.71875.15
28. Wagner C, Heck D, Lautenschläger K, et al. T-lymphocytes in implant-associated posttraumatic osteomyelitis: identification of cytotoxic T-effector cells at the site of infection. Shock. 2006;25:241-246. Medline. doi:10.1097/01. shk.0000192119.68295.14
29. Günther F, Wabnitz GH, Stroh P, et al. Host defence against Staphylococcus aureus biofilms infection: Phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol Immunol. 2009;46:1805-1813. Medline. doi:10.1016/j.molimm. 2009.01.020
30. Guenther F, Stroh P, Wagner C, Obst U, Hänsch GM. Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. Int J Artif Organs. 2009;32(2):565-573.
31. Stroh P, Günther F, Meyle E, Prior B, Wagner C, Hänsch GM. Host defence against Staphylococcus aureus biofilms by polymorphonuclear neutrophils: oxygen radical production but not phagocytosis depends on opsonisation with immunoglobulin G. Immunobiology. 2011;216(3):351-357. Medline. doi:10.1016/j.imbio.2010.07.009
32. Meyle E, Stroh P, Günther F, Hoppy-Tichy T, Wagner C, Hänsch GM. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation. Int J Artif Organs. 2010;33(9):608-620.
33. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28(11):1062-1068.
34. Costerton JW, Montanaro L, Arciola CR. Bacterial communication in implant infections: a target for an intelligence war. Int J Artif Organs. 2007;30(9):757-763.
35. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623-633.
36. Jefferson K. What drives bacteria to produce a biofilm? FEMS Microbiol Lett. 2004;236(2):163-173.
37. Moscoso M, Garcia E, Lopez R. Biofilm formation by Streptococcus pneumonia: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006;188(22):7785-7795. Medline. doi:10.1128/JB.00673-06
38. Tolker-Nielsen T, Brinch UC, Ragas PC, Andersen JB, Jacobsen CS, Molin S. Development and dynamics of Pseudomonas sp. biofilms. J Bacteriol. 2000;182:6482-6489 Medline. doi:10.1128/JB.182.22.6482-6489.2000
39. Gjermansen M, Ragas P, Sternberg C, Molin S, Tolker-Nielsen T. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms. Environ Microbiol. 2005;7:894-906. Medline. doi:10.1111/j.1462-2920.2005.00775.x
40. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol. 2010;59(3):253-268.
41. Pavithra D, Doble M. Biofilm formation, bacterial adhesion and host responseon polymeric implants - issues and prevention. Biomed Mater. 2008;3(3):034003. Medline. doi:10.1088/1748-6041/3/3/034003
42. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol. 1995;103(4):466-471.
43. Padera RF. Infection in ventricular assist devices: the role of biofilm. Cardiovasc Pathol. 2006;15(5):264-270. Medline. doi:10.1016/j.carpath.2006.04.008
44. Dunne WM. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002;15(2):155-166. Medline. doi:10.1128/CMR.15.2.155-166.2002
45. Schnettler R, Alt V. Pathophysiologie und Klassifikation der Osteitis. In: Steinau HU, eds. Septische Knochenchirurgie. Schnettler R, Stuttgart: Thieme Verlag 2004;5-14.
46. Hastings JW. Bacterial quorum-sensing signals are inactivated by mammalian cells. Proc Natl Acad Sci USA. 2004;101(12):3993-3994. Medline. doi:10.1073/ pnas.0400874101
47. Chun CK, Ozer E, Welsh MJ, Zabner J, Greenberg EP. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airways epithelia. Proc Natl Acad Sci USA. 2004;101(10):3587-3590. Medline. doi:10.1073/ pnas.0308750101
48. Arciola CR. New concepts and new weapons in implant infections. Int J Artif Organs. 2009;32(9):533-536.
49. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 2010;59(3):227-238.
50. Ramage G, Culshaw S, Jones B, Williams C. Are we any closer to beating the biofilm: novel methods of biofilm control. Curr Opin Infect Dis. 2010;23(6):560-566. Medline. doi:10.1097/ QCO.0b013e32833e5850
51. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic coated implants: a review. Injury. 2006;37(2):S105-S112. doi:10.1016/j.injury.2006.04.016
52. Neut D, Kluin OS, Crielaard BJ, et al. A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthop. 2009;80(5):514-519. Medline. doi:10.3109/17453670903350040
53. Jabbouri S, Sadovskaya I. Characteristics of the biofilm matrix and its role as a possible target for the detection and eradication of Staphylococcus epidermidis associated with medical implant infections. FEMS Immunol Med Microbiol. 2010;59(3):280-291.
54. Del Pozo JL, Alonso M, Arciola CR, et al. Biotechnological war against biofilms. Could phages mean the end of device- related infections. Int J Artif Organs. 2007;30(9):805-812.